Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: A Phase I Randomized, Observer-Blinded, Dose-Ranging Study in Healthy Subjects 24 to <72 Months of Age [Phase 1]
Phase I randomized, observer-blinded, dose-ranging study of an RSV vaccine in healthy children aged 24 to under 72 months completed.
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: RSV001 - A New Vaccine to Prevent Severe Viral Chest Infections. [Phase 1]
Phase 1 trial of the RSV001 vaccine to prevent severe respiratory syncytial virus infections has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: Safety, Tolerability and PK Study of AK0529 in Healthy Human [Phase 1]
Phase 1 safety, tolerability, and pharmacokinetics study of AK0529 in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: A Study in Japanese Children Hospitalized With Respiratory Syncytial Virus Related Lower Respiratory Tract Infections
A completed clinical trial update involving Japanese children hospitalized with RSV-related lower respiratory tract infections. The study co…
-
CLINICAL_TRIALS trial_result · 2015-07-10Clinical Trial Update: Surveillance of Synagis in Korean Pediatric Patients
A completed surveillance trial examining palivizumab (Synagis) use in Korean pediatric patients for respiratory syncytial virus infection, w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-09-03Clinical Trial Update: A One-Year Observation of Palivizumab in Infants at Risk for Respiratory Syncytial Virus Infection in Latin America
A one-year observational study of Palivizumab in infants at risk for respiratory syncytial virus infection in Latin America has been complet…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: An Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHF
An observational study evaluating RSV-associated illness in adults with COPD and/or congestive heart failure has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: RSV-F Vaccine Dose Ranging Study in Young Women [Phase 2]
The RSV-F vaccine dose-ranging study in young women (Phase 2) has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly [Phase 1]
A Phase 1 trial evaluating co-administration of an RSV-F vaccine with an influenza vaccine in elderly participants has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-07Clinical Trial Update: MEDI-557 Adult Dosing [Phase 1]
Phase 1 trial update provides adult dosing information for MEDI-557 in Respiratory Syncytial Virus. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children [Phase 3]
Phase 3 trial results for Motavizumab (MEDI-524) in preventing serious RSV disease in high-risk children have been completed and results pos…
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions [Phase 3]
Phase 3 trial evaluating Palivizumab for prevention of Respiratory Syncytial Virus infection in Japanese newborns, infants, and young childr…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: A Phase 1 Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of GS-5806 [Phase 1]
Phase 1 study evaluating pharmacokinetics, metabolism, and excretion of GS-5806 (Presatovir) in respiratory syncytial virus infection; study…
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Motavizumab (MEDI-524) After Dosing for a Second Season in Children [Phase 1, Phase 2]
This clinical trial update reports on safety, tolerability, and immunogenicity results for a second RSV prophylaxis season with Motavizumab …
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: Burden of Respiratory Syncytial Virus (RSV) in the United Kingdom From 1995 to 2009
This completed clinical trial update describes the burden of respiratory syncytial virus infection in the United Kingdom from 1995 to 2009, …
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness [Phase 2]
A Phase 2 study update reports the results of RI-001 in immunosuppressed patients infected with Respiratory Syncytial Virus at risk for lowe…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Sofia RSV FIA Field Study
Quidel's Sofia RSV FIA field study for respiratory syncytial virus has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Study of Motavizumab (MEDI-524) and Palivizumab Administered Sequentially in the Same Respiratory Syncytial Virus (RSV) Season [Phase 2]
A Phase 2 trial evaluated sequential administration of motavizumab and palivizumab during an RSV season in infants at risk for RSV infection…
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 - 35 wGA
Clinical trial update reporting the completion and posting of results for a study evaluating compliance with Synagis (palivizumab) in premat…
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Collection and Testing of Respiratory Samples
A completed clinical trial assessing collection and testing of respiratory samples using the QIAGEN ResPlex II Advanced Panel and Artus Infl…
-
CLINICAL_TRIALS trial_result · 2012-04-23Clinical Trial Update: Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection
A completed trial evaluated the effectiveness of palivizumab immunoprophylaxis (Synagis) in high-risk preterm infants to prevent severe RSV …
-
CLINICAL_TRIALS trial_result · 2012-04-09Clinical Trial Update: Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age [Phase 1]
Phase 1 safety and tolerability study of MEDI-534 in infants 6 to <24 months with viral respiratory infections, including RSV and parainflue…
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine [Phase 1]
This clinical trial update reports that a Phase 1 safety study of Novavax's RSV-F protein particle vaccine for Respiratory Syncytial Virus i…
-
CLINICAL_TRIALS trial_result · 2011-12-19Clinical Trial Update: Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian Children
Completed clinical trial sponsored by Abbott assessing the incidence of severe Respiratory Syncytial Virus infections in preterm Brazilian c…
-
CLINICAL_TRIALS trial_result · 2011-07-19Clinical Trial Update: Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children [Phase 2, Phase 3]
Phase 2/3 clinical trial update on palivizumab for prevention of severe respiratory syncytial virus infection in high-risk Russian infants, …